Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids - Tập 1851 - Trang 19-29 - 2015
Tài liệu tham khảo
Chiang, 2009, Bile acids: regulation of synthesis, J. Lipid Res., 50, 1955, 10.1194/jlr.R900010-JLR200
Pullinger, 2002, Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype, J. Clin. Invest., 110, 109, 10.1172/JCI0215387
Hylemon, 2009, Bile acids as regulatory molecules, J. Lipid Res., 50, 1509, 10.1194/jlr.R900007-JLR200
Makishima, 1999, Identification of a nuclear receptor for bile acids, Science, 284, 1362, 10.1126/science.284.5418.1362
Parks, 1999, Bile acids: natural ligands for an orphan nuclear receptor, Science, 284, 1365, 10.1126/science.284.5418.1365
Wang, 1999, Endogenous bile acids are ligands for the nuclear receptor FXR/BAR, Mol. Cell, 3, 543, 10.1016/S1097-2765(00)80348-2
Kawamata, 2003, A G protein-coupled receptor responsive to bile acids, J. Biol. Chem., 278, 9435, 10.1074/jbc.M209706200
Maruyama, 2002, Identification of membrane-type receptor for bile acids (M-BAR), Biochem. Biophys. Res. Commun., 298, 714, 10.1016/S0006-291X(02)02550-0
Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab., 10, 167, 10.1016/j.cmet.2009.08.001
Alemi, 2013, The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice, Gastroenterology, 144, 145, 10.1053/j.gastro.2012.09.055
Keitel, 2009, The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders, Hepatology, 50, 861, 10.1002/hep.23032
Keitel, 2010, The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes, Biol. Chem., 391, 785, 10.1515/bc.2010.077
Studer, 2012, Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes, Hepatology, 55, 267, 10.1002/hep.24681
Inagaki, 2005, Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis, Cell Metab., 2, 217, 10.1016/j.cmet.2005.09.001
Dent, 2005, Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes, Hepatology, 42, 1291, 10.1002/hep.20942
Stravitz, 1996, Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7α-hydroxylase, Am. J. Physiol., 34, G293
Song, 2007, Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes, Hepatology, 46, 1993, 10.1002/hep.21878
Seok, 2013, Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase czeta is critical for epigenomic regulation of liver metabolic genes, J. Biol. Chem., 288, 23252, 10.1074/jbc.M113.452037
Jahan, 2005, Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene, Am. J. Physiol. Gastrointest. Liver Physiol., 288, G685, 10.1152/ajpgi.00207.2004
Li, 2006, Bile acids and cytokines inhibit the human cholesterol 7alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells, Hepatology, 43, 1202, 10.1002/hep.21183
Hait, 2009, Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate, Science, 325, 1254, 10.1126/science.1176709
Schoenfield, 1981, Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety, Ann. Intern. Med., 95, 257, 10.7326/0003-4819-95-3-257
Garg, 1994, Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial, Ann. Intern. Med., 121, 416, 10.7326/0003-4819-121-6-199409150-00004
Angelin, 1978, Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia, J. Lipid Res., 19, 1017, 10.1016/S0022-2275(20)40685-6
Zhang, 2006, Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice, Proc. Natl. Acad. Sci. U. S. A., 103, 1006, 10.1073/pnas.0506982103
Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J. Clin. Invest., 113, 1408, 10.1172/JCI21025
Ma, 2006, Farnesoid X receptor is essential for normal glucose homeostasis, J. Clin. Invest., 116, 1102, 10.1172/JCI25604
Lundasen, 2006, Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man, J. Intern. Med., 260, 530, 10.1111/j.1365-2796.2006.01731.x
Tomlinson, 2002, Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity, Endocrinology, 143, 1741, 10.1210/endo.143.5.8850
Fu, 2004, Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes, Endocrinology, 145, 2594, 10.1210/en.2003-1671
Potthoff, 2011, FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway, Cell Metab., 13, 729, 10.1016/j.cmet.2011.03.019
Kir, 2011, FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis, Science, 331, 1621, 10.1126/science.1198363
Bhatnagar, 2009, Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis, J. Biol. Chem., 284, 10023, 10.1074/jbc.M808818200
Miyata, 2011, Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice, Biol. Pharm. Bull., 34, 1885, 10.1248/bpb.34.1885
Miyake, 2002, Transgenic expression of cholesterol-7α-hydroxylase prevents atherosclerosis in C57BL/6J mice, Arterioscler. Thromb. Vasc. Biol., 22, 121, 10.1161/hq0102.102588
Li, 2010, Transgenic expression of cholesterol 7α-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice, Hepatology, 52, 678, 10.1002/hep.23721
Li, 2013, Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice, Hepatology, 58, 1111, 10.1002/hep.26427
Li, 2011, Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis, Hepatology, 53, 996, 10.1002/hep.24107
Nicholson, 1999, 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data, Xenobiotica, 29, 1181, 10.1080/004982599238047
Nicholson, 2002, Metabonomics: a platform for studying drug toxicity and gene function, Nat. Rev. Drug Discov., 1, 153, 10.1038/nrd728
Oresic, 2006, Metabolomic approaches to phenotype characterization and applications to complex diseases, Expert. Rev. Mol. Diagn., 6, 575, 10.1586/14737159.6.4.575
Hartler, 2013, Bioinformatics tools and challenges in structural analysis of lipidomics MS/MS data, Brief. Bioinform., 14, 375, 10.1093/bib/bbs030
Murphy, 2013, Lipidomics applications in health, disease and nutrition research, Mol. Nutr. Food Res., 57, 1336, 10.1002/mnfr.201200863
Li, 2013, Metabolomics reveals that tumor xenografts induce liver dysfunction, Mol. Cell. Proteomics, 12, 2126, 10.1074/mcp.M113.028324
Johnson, 2012, Novel metabolites and roles for alpha-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics, Am. J. Clin. Nutr., 96, 818, 10.3945/ajcn.112.042929
Matsubara, 2012, Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis, Cell Metab., 16, 634, 10.1016/j.cmet.2012.10.006
Patterson, 2011, Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling, Cancer Res., 71, 6590, 10.1158/0008-5472.CAN-11-0885
Miyake, 2001, Increased production of Apo B100-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7α- hydroxylase, J. Biol. Chem., 276, 23304, 10.1074/jbc.M101853200
Jonsson, 2005, Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets, Analyst, 130, 701, 10.1039/B501890K
Hannun, 1994, The sphingomyelin cycle and the second messenger function of ceramide, J. Biol. Chem., 269, 3125, 10.1016/S0021-9258(17)41834-5
Hammad, 2010, Blood sphingolipidomics in healthy humans: impact of sample collection methodology, J. Lipid Res., 51, 3074, 10.1194/jlr.D008532
Li, 2013, Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: method development and application in hepatocellular carcinoma, J. Chromatogr. A, 1320, 103, 10.1016/j.chroma.2013.10.064
Alewijnse, 2008, Sphingolipid signalling in the cardiovascular system: good, bad or both?, Eur. J. Pharmacol., 585, 292, 10.1016/j.ejphar.2008.02.089
Wiklund, 2008, Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models, Anal. Chem., 80, 115, 10.1021/ac0713510
Kong, 2012, Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice, Hepatology, 56, 1034, 10.1002/hep.25740
Sayin, 2013, Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist, Cell Metab., 17, 225, 10.1016/j.cmet.2013.01.003
Chanda, 2009, Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner, Hepatology, 50, 880, 10.1002/hep.23049
Garcia-Canaveras, 2011, A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations, J. Proteome Res., 10, 4825, 10.1021/pr200629p
Beyoglu, 2013, The metabolomic window into hepatobiliary disease, J. Hepatol., 59, 842, 10.1016/j.jhep.2013.05.030
Chavez, 2012, A ceramide-centric view of insulin resistance, Cell Metab., 15, 585, 10.1016/j.cmet.2012.04.002
Blachnio-Zabielska, 2012, Ceramide metabolism is affected by obesity and diabetes in human adipose tissue, J. Cell. Physiol., 227, 550, 10.1002/jcp.22745
Galadari, 2013, Role of ceramide in diabetes mellitus: evidence and mechanisms, Lipids Health Dis., 12, 98, 10.1186/1476-511X-12-98
Jin, 2013, Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages, Am. J. Physiol. Endocrinol. Metab., 305, E853, 10.1152/ajpendo.00251.2013
Chocian, 2010, High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei, Mol. Cell. Biochem., 340, 125, 10.1007/s11010-010-0409-6
Gupta, 2004, Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes: role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation, J. Biol. Chem., 279, 5821, 10.1074/jbc.M310979200
Haeusler, 2013, Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids, Diabetes, 62, 4184, 10.2337/db13-0639
Aron-Wisnewsky, 2013, Gut microbiota and non-alcoholic fatty liver disease: new insights, Clin. Microbiol. Infect., 19, 338, 10.1111/1469-0691.12140
Swann, 2011, Systemic gut microbial modulation of bile acid metabolism in host tissue compartments, Proc. Natl. Acad. Sci. U. S. A., 108, 4523, 10.1073/pnas.1006734107
Miyata, 2009, Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression, J. Pharmacol. Exp.Ther., 331, 1079, 10.1124/jpet.109.160093
Hu, 2014, Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism, J. Intern. Med., 275, 27, 10.1111/joim.12140
David, 2013, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820
Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice, Nature, 487, 104, 10.1038/nature11225